120 related articles for article (PubMed ID: 33285775)
1. Association between functional polymorphisms in the flanking region of miR-143/145 and risk of papillary thyroid carcinoma: A case-control study.
Wang Y; Zhou S; Zhao W; Li Z; Zhu J; Wei T; Song H
Medicine (Baltimore); 2020 Dec; 99(49):e23560. PubMed ID: 33285775
[TBL] [Abstract][Full Text] [Related]
2. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
Dong G; Zhang R; Xu J; Guo Y
Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
[TBL] [Abstract][Full Text] [Related]
3. Association Between Genetic Polymorphisms in the Promoter Regions of Let-7 and Risk of Papillary Thyroid Carcinoma: A Case-Control Study.
Wang Y; Wei T; Xiong J; Chen P; Wang X; Zhang L; Gao L; Zhu J
Medicine (Baltimore); 2015 Oct; 94(43):e1879. PubMed ID: 26512603
[TBL] [Abstract][Full Text] [Related]
4. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
[TBL] [Abstract][Full Text] [Related]
5. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
[TBL] [Abstract][Full Text] [Related]
6. A functional variant rs353292 in the flanking region of miR-143/145 contributes to the risk of colorectal cancer.
Yuan F; Sun R; Li L; Jin B; Wang Y; Liang Y; Che G; Gao L; Zhang L
Sci Rep; 2016 Jul; 6():30195. PubMed ID: 27444415
[TBL] [Abstract][Full Text] [Related]
7. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
8. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
9. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
Ai L; Yu Y; Liu X; Wang C; Shi J; Sun H; Yu Q
Front Med; 2014 Mar; 8(1):113-7. PubMed ID: 24452548
[TBL] [Abstract][Full Text] [Related]
10. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
[TBL] [Abstract][Full Text] [Related]
11. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma.
Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S
Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375
[TBL] [Abstract][Full Text] [Related]
12. Association between the rs2910164 polymorphism in pre-Mir-146a sequence and thyroid carcinogenesis.
Wei WJ; Wang YL; Li DS; Wang Y; Wang XF; Zhu YX; Yang YJ; Wang ZY; Ma YY; Wu Y; Jin L; Ji QH; Wang JC
PLoS One; 2013; 8(2):e56638. PubMed ID: 23451063
[TBL] [Abstract][Full Text] [Related]
13. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.
Maruei-Milan R; Heidari Z; Salimi S
J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972
[TBL] [Abstract][Full Text] [Related]
14. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
15. The effect of CASP3 rs4647610 and rs4647602 polymorphisms on tumour size and cancer stage in papillary thyroid carcinoma.
Heidari Z; Eskandari M; Aryan A; Rostamzad F; Salimi S
Br J Biomed Sci; 2020 Jul; 77(3):129-134. PubMed ID: 32151194
[TBL] [Abstract][Full Text] [Related]
16. miR-146a rs2910164 Polymorphism and Risk of Papillary Thyroid Carcinoma: A Meta-Analysis.
Chen H; Zhang H; Liu Y; Chen Z; Gu J; Cui D; Yang T
Genet Test Mol Biomarkers; 2018 Dec; 22(12):674-679. PubMed ID: 30484703
[No Abstract] [Full Text] [Related]
17. Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese.
Li H; Dai H; Li H; Li B; Shao Y
Curr Mol Med; 2019; 19(6):443-451. PubMed ID: 31288714
[TBL] [Abstract][Full Text] [Related]
18. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma.
Jazdzewski K; Murray EL; Franssila K; Jarzab B; Schoenberg DR; de la Chapelle A
Proc Natl Acad Sci U S A; 2008 May; 105(20):7269-74. PubMed ID: 18474871
[TBL] [Abstract][Full Text] [Related]
19. Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma.
Jiang R; Zhao C; Xu H; Zhao M; Sun X; Wang X; Song W
Clin Endocrinol (Oxf); 2016 Mar; 84(3):431-7. PubMed ID: 25916409
[TBL] [Abstract][Full Text] [Related]
20. Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.
Park SW; Kim MK; Kwon KH; Kim J
Int J Immunogenet; 2012 Dec; 39(6):501-7. PubMed ID: 22594576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
